Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation

Journal of Lipid Research

Volumn 52, Issue 4, 2011, Pages 759-770

  Kim, Su Jin ^a   Nian, Cuilan ^a   McIntosh, Christopher H S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adipocytes; Diabetes; Gene expression; Obesity; Peroxisome proliferator activated receptor

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; HISTONE H3; HISTONE H4; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TOMELUKAST;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENE CONTROL; HISTONE ACETYLATION; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

3T3-L1 CELLS; ACETYLATION; ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; HISTONES; IMMUNOPRECIPITATION; MICE; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, GASTROINTESTINAL HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 79953307026     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012203     Document Type: Article

References (54)

1. Brubaker, P. L., and D. J. Drucker. 2004. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology. 145: 2653-2659.
2. Drucker, D. J. 2007. The role of gut hormones in glucose homeostasis. J. Clin. Invest. 117: 24-32.
3. Yusta, B., L. Baggio, J. L. Estall, J. A. Koehler, D. P. Holland, H. Li, D. Pipeleers, Z. Ling, and D. J. Drucker. 2006. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 4: 391-406.
4. McIntosh, C. H. S., S. Widenmaier, and S. J. Kim. 2009. Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP). Vitam. Horm. 80: 409-471.
5. Ehses, J. A., V. R. Casilla, T. Doty, J. A. Pospisilik, K. D. Winter, H. U. Demuth, R. A. Pederson, and C. H. S. McIntosh. 2003. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology. 144: 4433-4445.
6. Kim, S. J., K. Winter, C. Nian, M. Tsuneoka, Y. Koda, and C. H. S. McIntosh. 2005. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and downregulation of bax expression. J. Biol. Chem. 280: 22297-22307.
7. Kim, S. J., C. Nian, S. Widenmaier, and C. H. S. McIntosh. 2008. Glucose-dependent Insulinotropic Polypeptide (GIP) mediated upregulation of β-cell anti-apoptotic Bcl-2 gene expression is coordinated by cAMP-response element binding protein (CREB) and cAMP-responsive CREB coactivator 2 (TORC2). Mol. Cell. Biol. 28: 1644-1656.
8. Widenmaier, S. B., Z. Ao, S. J. Kim, G. Warnock, and C. H. S. McIntosh. 2009. Suppression of p38 MAPK and JNK via Akt-mediated inhibition of Apoptosis Signal regulating Kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J. Biol. Chem. 284: 30372-30382.
9. Widenmaier, S. B., S. J. Kim, G. K. Yang, T. De Los Reyes, C. Nian, A. Asadi, Y. Seino, T. J. Kieffer, Y. N. Kwok, and C. H. S. McIntosh. 2010. A GIP receptor agonist exhibits β-cell anti-apoptotic actions in rat models of diabetes resulting in improved β-cell function and glycemic control. PLoS ONE. 5: e9590.
10. Drucker, D. J., and M. A. Nauck. 2006. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 368: 1696-1705.
11. Davidson, M. B., G. Bate, and P. Kirkpatrick. 2005. Exenatide. Nat. Rev. Drug Discov. 4: 713-714.
12. Harder, H., L. Nielsen, D. T. T. Tu, and A. Astrup. 2004. The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care. 27: 1915-1921.
13. DeFronzo, R. A., R. E. Ratner, J. Han, D. D. Kim, M. S. Fineman, and A. D. Baron. 2005. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 28: 1092-1100.
14. Deacon, C. F. 2007. Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes. Expert Opin. Investig. Drugs. 16: 533-545.
15. Rosenstock, J., M. A. Baron, S. Dejager, D. Mills, and A. Schweizer. 2007. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Care. 30: 217-223.
16. McIntosh, C. H. 2008. Dipeptidyl peptidase IV inhibitors and diabetes therapy. Front. Biosci. 13: 1634-1645.
17. Miyawaki, K., Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, H. Zhou, S. Fujimoto, A. Oku, K. Tsuda, S. Toyokuni, et al. 2002. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat. Med. 8: 738-742.
18. Kieffer, T. J. 2003. GIP or not GIP? That is the question. Trends Pharmacol. Sci. 24: 110-112.
19. Gault, V. A., F. P. O'Harte, and P. R. Flatt. 2003. Glucose-dependent insulinotropic polypeptide (GIP): antidiabetic and anti-obesity potential? Neuropeptides. 37: 253-263.
20. Song, D. H., L. Getty-Kaushik, E. Tseng, J. Simon, B. E. Corkey, and M. M. Wolfe. 2007. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology. 133: 1796-1805.
21. Weaver, R. E., D. Donnelly, M. Wabitsch, P. J. Grant, and A. J. Balmforth. 2008. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model. Int. J. Obes. (Lond). 32: 1705-1711.
22. Prins, J. B., and S. O'Rahilly. 1997. Regulation of adipose cell number in man. Clin. Sci. 92: 3-11.
23. Rosen, E. D., and B. M. Spiegelman. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16: 145-171.
24. Gregoire, F. M., C. M. Smas, and H. S. Sul. 1998. Understanding adipocyte differentiation. Physiol. Rev. 78: 783-809.
25. Sethi, J. K., and A. J. Vidal-Puig. 2007. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48: 1253-1262.
26. McIntosh, C. H. S., I. Bremsak, F. C. Lynn, R. Gill, S. A. Hinke, R. Gelling, C. Nian, G. McKnight, S. Jaspers, and R. A. Pederson. 1999. Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endocrinology. 140: 398-404.
27. Kim, S. J., C. Nian, and C. H. S. McIntosh. 2007. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J. Biol. Chem. 282: 8557-8567.
28. Kim, S. J., C. Nian, and C. H. S. McIntosh. 2007. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J. Biol. Chem. 282: 34139-34147.
29. Kim, S. J., C. Nian, and C. H. McIntosh. 2010. GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene. J. Lipid Res. 51: 3145-3157.
30. Ramirez-Zacarias, J. L., F. Castro-Mufiozledo, and W. Kuri-Harcuch. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97: 493-497.
31. Rudolf, M., and C. A. Curcio. 2009. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 57: 731-739.
32. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
33. Gupta, D., M. Peshavaria, N. Monga, T. L. Jetton, and J. L. Leahy. 2010. Physiologic and pharmacologic modulation of GIP receptor expression in beta-cells by PPARγ signaling: possible mechanism for the GIP resistance in Type 2 diabetes. Diabetes. 59: 1445-1450.
34. Lynn, F. C., S. A. Thompson, J. A. Pospisilik, J. A. Ehses, S. A. Hinke, N. Pamir, C. H. S. McIntosh, and R. A. Pederson. 2003. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells. FASEB J. 17: 91-93.
35. Lynn, F. C., N. Pamir, E. H. Ng, C. H. S. McIntosh, T. J. Kieffer, and R. A. Pederson. 2001. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes. 50: 1004-1011.
36. Chawla, A., and M. A. Lazar. 1994. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. U S A. 91: 1786-1790.
37. Smith, P. J., L. S. Wise, R. Berkowitz, C. Wan, and C. S. Rubin. 1988. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J. Biol. Chem. 263: 9402-9408.
38. Benito, M., A. Valverde, and M. Lorenzo. 1996. IGF-I: a mitogen also involved in differentiation processes in mammalian cells. Int. J. Biochem. Cell Biol. 28: 499-510.
39. Cinti, S., S. Eberbach, M. Castellucci, and D. Accili. 1998. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis. Diabetologia. 41: 171-177.
40. Nakae, J., T. Kitamura, Y. Kitamura, W. H. Biggs, K. Arden, and D. Accili. 2003. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell. 4: 119-129.
41. Miki, H., T. Yamauchi, R. Suzuki, K. Komeda, A. Tsuchida, N. Kubota, Y. Terauchi, J. Kamon, Y. Kaburagi, J. Matsui, et al. 2001. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol. Cell. Biol. 21: 2521-2532.
42. Bäck, K., H. J. Arnqvist, K. Bäck, and H. J. Arnqvist. 2009. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm. IGF Res. 19: 101-111.
43. Modan-Moses, D., M. Janicot, J. C. McLenithan, M. D. Lane, and S. J. Casella. 1998. Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Biochem. J. 333: 825-831.
44. Xu, G., H. Kaneto, D. R. Laybutt, V. F. Duvivier-Kali, N. Trivedi, K. Suzuma, G. L. King, G. C. Weir, and S. Bonner-Weir. 2007. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes. 56: 1551-1558.
45. Nadeau, K. J., J. W. Leitner, I. Gurerich, and B. Draznin. 2004. Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes. J. Biol. Chem. 279: 34380-34387.
46. Yellaturu, C. R., X. Deng, E. A. Park, R. Raghow, and M. B. Elam. 2009. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional downregulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex. J. Biol. Chem. 284: 31726-31734.
47. Kim, J. B., H. M. Wright, M. Wright, and B. M. Spiegelman. 1998. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. U S A. 95: 4333-4337.
48. Leesnitzer, L. M., D. J. Parks, R. K. Bledsoe, J. E. Cobb, J. L. Collins, T. G. Consler, R. G. Davis, E. A. Hull-Ryde, J. M. Lenhard, L. Patel, et al. 2002. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry. 41: 6640-6650.
49. Wellen, K. E., G. Hatzivassiliou, U. M. Sachdeva, T. V. Bui, J. R. Cross, and C. B. Thompson. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 324: 1076-1080.
50. Yoo, E. J., J. J. Chung, S. S. Choe, K. H. Kim, and J. B. Kim. 2006. Downregulation of histone deacetylases stimulates adipocyte differentiation. J. Biol. Chem. 281: 6608-6615.
51. Steger, D. J., G. R. Grant, M. Schupp, T. Tomaru, M. I. Lefterova, J. Schug, E. Manduchi, C. J. Stoeckert, Jr., and M. A. Lazar. 2010. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 24: 1035-1044.
52. Kim, S. J., C. Nian, and C. H. S. McIntosh. 2009. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 modulate beta-cell chromatin structure. J. Biol. Chem. 284: 12896-12904.
53. Maida, A., B. J. Lamont, X. Cao, and D. J. Drucker. 2011. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice. Diabetologia. 54: 339-349.
54. Kota, B. P., T. H. Huang, and B. D. Roufogalis. 2005. An overview on biological mechanisms of PPARs. Pharmacol. Res. 51: 85-94.